Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cortisone Treatment in Vestibular Neuritis
2014-005484-32Phase 4Active
- Sponsor
- Lund University
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of betamethasone and prednisolone in vestibular neuritis, Vestibular nerve injury and acute vestibular syndrome (AVS) (3 arms), sponsored by Lund University. Primary endpoint: Caloric response. Started Mar 2015; status: active.
02
Drugs
betamethasoneprednisolone
03
Conditions
vestibular neuritisVestibular nerve injuryacute vestibular syndrome (AVS)
Beyond the preview
Go deeper on 2014-005484-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005484-32.